Exploring the interconnected pathobiology between Crohn's disease, ulcerative colitis and colorectal cancer through gene expression, pathway analysis and immune profiling
{"title":"Exploring the interconnected pathobiology between Crohn's disease, ulcerative colitis and colorectal cancer through gene expression, pathway analysis and immune profiling","authors":"Sonia Chadha","doi":"10.1016/j.humgen.2025.201404","DOIUrl":null,"url":null,"abstract":"<div><div>Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), share immune dysregulation mechanisms with colorectal cancer (CRC). This study analyzed gene expression datasets (GSE75214: 74 UC, 8 CD, 11 controls; GSE110224: 17 CRC, matched controls) to identify differentially expressed genes (DEGs), enriched pathways, and hub genes. Gene Ontology and pathway analyses highlighted inflammatory response, chemokine activity, and cytokine signalling. Immune infiltration analysis (CIBERSORTx) revealed distinct immune cell patterns, including increased mast cells, M1 macrophages, and neutrophils in CD, UC, and CRC, with activated dendritic cells present only in CD and UC. Protein-protein interaction (PPI) analysis identified hub genes common to CD, UC, and CRC (e.g., IL1B, CXCL8, CD44), which correlated with immune infiltration. GEPIA validation confirmed their relevance in CRC. These findings suggest a regulatory cross talk between gene expression and immune modulation, shedding light on the molecular mechanisms underlying IBD-associated CRC. The study provides potential biomarkers and therapeutic targets for early diagnosis and intervention.</div></div>","PeriodicalId":29686,"journal":{"name":"Human Gene","volume":"44 ","pages":"Article 201404"},"PeriodicalIF":0.5000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Gene","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2773044125000300","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), share immune dysregulation mechanisms with colorectal cancer (CRC). This study analyzed gene expression datasets (GSE75214: 74 UC, 8 CD, 11 controls; GSE110224: 17 CRC, matched controls) to identify differentially expressed genes (DEGs), enriched pathways, and hub genes. Gene Ontology and pathway analyses highlighted inflammatory response, chemokine activity, and cytokine signalling. Immune infiltration analysis (CIBERSORTx) revealed distinct immune cell patterns, including increased mast cells, M1 macrophages, and neutrophils in CD, UC, and CRC, with activated dendritic cells present only in CD and UC. Protein-protein interaction (PPI) analysis identified hub genes common to CD, UC, and CRC (e.g., IL1B, CXCL8, CD44), which correlated with immune infiltration. GEPIA validation confirmed their relevance in CRC. These findings suggest a regulatory cross talk between gene expression and immune modulation, shedding light on the molecular mechanisms underlying IBD-associated CRC. The study provides potential biomarkers and therapeutic targets for early diagnosis and intervention.